FENC vs JAZZ · rev $17.9M vs P/E 1988, rev $2.28B
Fennec Pharmaceuticals Inc (FENC) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FENC currently screens at market cap $302.2M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FENC and JAZZ stock pages for the full models.
Not investment advice.